FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and aims at HIV-infection treatment. That is ensured by introduction of a T-cell depletor which effectively disintegrates all T-cells of the patient. Said depletor is a CD52 monoclonal antibody Alemtuzumab.
EFFECT: invention allows suppressing the immune system by the controlled method.
8 cl, 2 ex, 2 dwg
Authors
Dates
2010-07-10—Published
2005-07-28—Filed